Author: Favalli, Ennio Giulio; Monti, Sara; Ingegnoli, Francesca; Balduzzi, Silvia; Caporali, Roberto; Montecucco, Carlomaurizio
Title: Incidence of COVIDâ€19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? Cord-id: 0di8j0lu Document date: 2020_6_7
ID: 0di8j0lu
Snippet: OBJECTIVES: To describe the incidence and severity of coronavirus disease 2019 (COVIDâ€19) in rheumatic patients treated with targeted synthetic or biological antiâ€rheumatic drugs (ts/bDMARDs) compared with the general population living in the same Italian region. METHODS: Patients followed at two referral rheumatology centres in Lombardy from 25(th) February to 10(th) April 2020 were invited to participate in a survey to detect patients with confirmed COVIDâ€19, close contacts with known CO
Document: OBJECTIVES: To describe the incidence and severity of coronavirus disease 2019 (COVIDâ€19) in rheumatic patients treated with targeted synthetic or biological antiâ€rheumatic drugs (ts/bDMARDs) compared with the general population living in the same Italian region. METHODS: Patients followed at two referral rheumatology centres in Lombardy from 25(th) February to 10(th) April 2020 were invited to participate in a survey to detect patients with confirmed COVIDâ€19, close contacts with known COVIDâ€19 cases, symptoms of infection, working, behavioural and disease management changes applied to prevent the contagion. The incidence of COVIDâ€19 in the Lombardy population was obtained from the National Institute of Statistics. Confirmed COVIDâ€19 was defined by nasopharyngeal swab. RESULTS: The survey was circulated amongst 955 patients (531 rheumatoid arthritis, 203 psoriatic arthritis, 181 spondyloarthritis, and 40 of connective tissue diseases/vasculitides/autoinflammatory diseases; mean age 53.7 years; female: 67.4%). The rate of responders was 98.05%. The incidence of confirmed COVIDâ€19 is consistent with the general population (0.62% vs 0.66%; p=0.92). None of the patients had severe complications or required intensive care treatment, and all of them temporarily discontinued ongoing ts/bDMARDs therapy. Almost all patients adopted precautions to prevent the contagion (90.6%) and maintained the ongoing treatment with ts/bDMARDs (93.2%). The disease activity remained stable in 89.5% of patients. CONCLUSIONS: Our results highlight the attitude from rheumatic patients to prevent the contagion while maintaining their chronic treatments. The incidence and severity of COVIDâ€19 in patients treated with ts/bDMARDs was not significantly different from that of the general population in the same region.
Search related documents:
Co phrase search for related documents- accepted article and acute sars respiratory syndrome coronavirus: 1, 2, 3, 4
- accurate picture and acute respiratory: 1, 2, 3, 4, 5
- accurate picture and acute sars respiratory syndrome coronavirus: 1, 2
Co phrase search for related documents, hyperlinks ordered by date